Embecta Corp. EMBC United States — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Embecta Corp. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Embecta Corp.'s united states — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Embecta Corp.'s united states — revenue?
- Embecta Corp. (EMBC) reported united states — revenue of $95.4M in Q1 2026.
- How has Embecta Corp.'s united states — revenue changed year-over-year?
- Embecta Corp.'s united states — revenue decreased by 29.4% year-over-year, from $135.2M to $95.4M.
- What is the long-term trend for Embecta Corp.'s united states — revenue?
- Over 4 years (2021 to 2025), Embecta Corp.'s united states — revenue has grown at a -1.3% compound annual growth rate (CAGR), from $609.4M to $579.1M.
- What does united states — revenue mean?
- This metric represents the total gross income generated from the sale of medical technology products and services within the United States geographic market. It serves as a primary indicator of the company's commercial performance, market penetration, and demand for its clinical solutions in the domestic region. Tracking this figure allows investors to assess regional growth trends and the effectiveness of local sales strategies.